Trial Profile
Desmopressin Melt: Impact on Sleep and Daytime Functioning? A Prospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2022
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary)
- Indications Urination disorders
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SLEEP
- 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 May 2014 According to a Ferring Pharmaceuticals media release, results presented at the 25th annual congress of the European Society for Paediatric urology (ESPU).
- 09 May 2014 Results published in the Media Release.